HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial

Part of paid clinical trials in Chandler, Arizona.

Sponsor
Population Health Research Institute
Study ID
NCT04743765
Status
Recruiting
Apply to this trial

Conditions

  • Hip Fractures
  • Myocardial Injury

Eligibility Criteria

Sex
ALL
Age
45 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Accelerated medical clearance and surgery — OTHER
    Rapid medical clearance with targeted arrival to the operating room within 6 hours of eligibility criteria criteria met.

Study Details

The HIP ATTACK-2 trial is a multicentre, international, parallel group randomized controlled trial to determine whether accelerated surgery for hip fracture in patients with acute myocardial injury is superior to standard care in reducing death at 90 days after randomization. The trial will also assess secondary outcomes at 90 days after randomization: inability to independently walk 3 metres, time to first mobilization (first standing and first full weight bear), composite and individual assessment of major complications (e.g., mortality, non-fatal myocardial infarction, acute congestive heart failure, and stroke), delirium, length of stay, pain, and quality of life.

Key Dates

First listed
Feb 8, 2021
Start date
Nov 22, 2021
Status verified
Sep 2025
Primary completion
Aug 31, 2027
Completion
Nov 30, 2027

Study Design

Enrollment
1,100 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Accelerated medical clearance and surgery
    Accelerated medical clearance and targeted arrival to the operating room within 6 hours of eligibility criteria met.
  • No Intervention: Standard surgical care
    Hip fracture repair and surgical care according to treating institution guidelines.

Primary Outcome Measure

All cause mortality [ Time Frame: Within 90 days post randomization ]

Central Contacts

Locations (23)

FacilityCityStateZIPSite coordinators
Chandler Regional Medical CenterChandlerArizona85224-
The Regents of the University of CaliforniaDavisCalifornia95618-
University of California, IrvineIrvineCalifornia92697-
Yale New Haven HospitalNew HavenConnecticut06520-
Emory University at Grady Memorial HospitalAtlantaGeorgia30322-
Sinai Hospital of BaltimoreBaltimoreMaryland21215-
University of MarylandBaltimoreMaryland20742-
Tufts Medical CenterBostonMassachusetts02111-
Lahey Hospital and Medical CenterBurlingtonMassachusetts01805-
University of MichiganAnn ArborMichigan48109-
Mayo ClinicRochesterMinnesota55905-
Bryan Medical CenterLincolnNebraska68506-
University Medical Center of Southern NevadaLas VegasNevada89102-
Dartmouth-Hitchcock Medical CenterLebanonNew Hampshire03756-
Montefiore Medical CenterThe BronxNew York10467-
Cleveland ClinicClevelandOhio44195-
Oregon Health and Science UniversityPortlandOregon97239-
St. Luke's University Health NetworkBethlehemPennsylvania18015-
The University of Texas Southwestern Medical Center (UTSW)DallasTexas75390-
The University of Texas Health Science Center at HoustonHoustonTexas77030-
University of UtahSalt Lake CityUtah84112-
University of WisconsinMadisonWisconsin53715-
Froedtert HospitalMilwaukeeWisconsin53226-

Find similar trials in Chandler, AZ

By research site
Chandler Regional Medical Center· Chandler, AZThe Regents of the University of California· Davis, CAUniversity of California, Irvine· Irvine, CAYale New Haven Hospital· New Haven, CTEmory University at Grady Memorial Hospital· Atlanta, GASinai Hospital of Baltimore· Baltimore, MD

Related Studies